FDA Inspection 1293760 — Kenichi Tanaka, MD
The FDA completed an inspection of Kenichi Tanaka, MD on Nov 20, 2025 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 20, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional details
Clinical Investigator (CI)